Top Markets
Coin of the day
ProtoKinetix, Incorporated ProtoKinetix, Incorporated

ProtoKinetix, Incorporated

PKTX
Rank in Stocks #40253
ProtoKinetix, Incorporated is a biotechnology firm engaged in research and... ProtoKinetix, Incorporated is a biotechnology firm engaged in research and development, specializing in the scientific and medical investigation of glycoproteins known as anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). These AFGPs are particularly relevant for their commercial potential within the healthcare sector, with a key area of their development involving utilizing AAGPs for the treatment of dry-eye conditions. Their research efforts are bolstered by a collaborative agreement with the University of British Columbia. Originally incorporated in 1999 as RJV Network, Inc., the company adopted its current name, ProtoKinetix, Incorporated, in July 2003. Its operational headquarters are situated in Marietta, Ohio.
Share Price
$0.0005
Last synced: 2026-08-12
Market Cap
$195.79K
Change (1 day)
25.00%
Change (1 year)
-92.09%
Country
US
Trade ProtoKinetix, Incorporated (PKTX)

Category

P/B ratio for ProtoKinetix, Incorporated (PKTX)
P/B ratio as of 2026 TTM: 0
According to ProtoKinetix, Incorporated latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for ProtoKinetix, Incorporated from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE